Resurgence of Eating Disorders with Olanzapine.
J Palliat Med
; 22(2): 231-233, 2019 Feb.
Article
en En
| MEDLINE
| ID: mdl-30376403
ABSTRACT
BACKGROUND:
Olanzapine is commonly utilized in palliative care for the treatment of nausea, and a known side effect of olanzapine is increased appetite. Olanzapine is also known to cause re-emergence of eating disorders (EDs) in patients utilizing olanzapine for its antipsychotic effects. It is unclear to what extent this may also occur in patients with serious/life-limiting illness. METHODS ANDRESULTS:
We present a case of a 70-year-old female with recurrent ovarian cancer and a history of bulimia nervosa (BN) that developed resurgence of her BN after initiation of olanzapine for cancer-associated nausea. Her BN resolved with reducing the dose of olanzapine.CONCLUSION:
It is important to recognize that recurrence of EDs can occur when using olanzapine in the palliative care setting.Palabras clave
Texto completo:
1
Colección:
01-internacional
Asunto principal:
Neoplasias Ováricas
/
Bulimia Nerviosa
/
Olanzapina
/
Náusea
/
Antineoplásicos
Límite:
Aged
/
Female
/
Humans
Idioma:
En
Revista:
J Palliat Med
Asunto de la revista:
SERVICOS DE SAUDE
Año:
2019
Tipo del documento:
Article